• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: March 25-29


ICYMI, this week we had news about bringing awareness to ethics in aesthetics, the 7 year anniversary of dupilumab's approval for atopic dermatitis, and more.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Pre- and Postemployment Contract Review: Safeguard Your Interests

By understanding employment contract essentials, dermatologists can ensure that their employment contract protects their interests and supports their career goals.

Current Treatment Options for Cutaneous Lupus Erythematosus Are 'Notably Inadequate,' Review Says

Researchers analyzed the current treatment and research landscape for CLE in a review published in the Journal of Dermatology.

Study Reveals Somatic and Habitual Predisposing Factors Topographically-Related to Body-Focused Repetitive Behaviors

Positive feelings accompanying BFRBs such as dermatillomania or trichotillomania may act as an important maintenance factor, researchers wrote.

POLL: Would You Consider Utilizing Virtual Reality in Your Practice or to Further Your Education?

Click here to answer today's poll and read more about recent uses of VR in dermatology education and practice.

Habits, Cultural Norms, and Rapid Advances In Technology Have Dramatically Changed the Aesthetic Medicine Landscape

Amy B. Lewis, MD, explores the evolution of aesthetic dermatology, delving into injection sophistication, devices, and top procedures.

In Psoriatic Arthritis, Psychosocial Factors Significantly Increase Risk of Joint Pain

Up to one quarter of patients with PsA experience persistent joint pain. In a recent study, higher levels of fatigue, depression, and anxiety were associated with joint pain.

Match Day 2024: A Look at Statistics on the Dermatology Match

We compare 2024 Match Day statistics with data from recent years.

Experts Develop Benefit-Risk Conceptual Framework for Biologic Use in Pregnancy

This framework considers both the pregnant patient who is taking the medication and the fetus who may be exposed to it while in the womb. It assesses potential benefits and risks for both parties.

Allergan Aesthetics Launches New Book to Bring More Awareness to Ethics in Aesthetics

Moving the Needle on Ethics includes articles and interviews featuring experts in aesthetics.

Tunlametinib Wins Approval in China for NRAS+ Advanced Melanoma After PD-1/PD-L1 Therapy

China’s NMPA has approved tunlametinib for the treatment of patients with NRAS-mutated advanced melanoma after prior anti–PD-1/PD-L1 therapy.

Melanoma and the Wrong Site

In this month's Legal Eagle column, learn about the liabilities and how to prevent wrong-site procedures.

Pointers With Portela: Providing Free Dermatologic Care

In this week’s Pointers With Portela, the 208SkinDoc reveals his journey toward providing free dermatologic care through a mobile clinic.

Amy Spizuoco, DO, FAOCD: Addressing STDs and Utilizing Dermatopathology With Care in Diverse Patient Populations

Spizuoco shares pearls from her sessions, "Infectious Diseases: The Story Behind STDs," and "Everything You Need to Know About Dermatopathology and the Dermatopathologist," from the Diversity in Dermatology conference.

A Spotlight on SCIN: A New Tool From Google and Researchers at Stanford Medicine

Researchers from Google and Stanford Medicine recently partnered to develop the Skin Condition Image Network dataset, a tool aimed at providing image resources for conditions across skin tones.

Reviewing Late-Breaking Research From AAD 2024

Catch up on late-breaking research shared at the 2024 American Academy of Dermatology Annual Meeting.

Dupilumab for Atopic Dermatitis: 7 Years Later

Today officially marks 7 years since the US FDA approved dupilumab for the treatment of atopic dermatitis. Here's a look back at its approval timeline and all it has accomplished in the dermatology world in the time since.

Skin Swab Analysis Reveals Early Predictors of Atopic Dermatitis in Infants

Researchers shared details of a noninvasive technique that detects abnormal inflammatory cytokine profiles in the skin of asymptomatic infant patients who subsequently develop AD.

Radiation Therapy Associated With Elevated Skin Cancer Risk in Patients With Breast Cancer

Discovering Dermatology Times: March 2024 Enhancing Psoriasis Management Supplement

Learn more about the in-depth topics covered in the March 2024 enhancing psoriasis management supplement of Dermatology Times.

Hidradenitis Suppurativa in Transgender and Gender-Diverse Patients and Hormone Therapy

Researchers found that patients who initiated gender-affirming hormone therapy with testosterone were more likely to experience a worsening of their HS symptoms.

Interview Intersection: Expert Interviews From March 2024

Dermatology Times is recapping our top expert interviews from the month of March.

Dermatology Times March 2024 Recap

Dermatology Times is looking back on the top stories in dermatology from the month of March.

EltaMD Rings Bell at New York Stock Exchange as Continued Celebration of National Dermatologist Day

EltaMD representatives and dermatologists partook in the celebration on March 28 as a continuation of the celebration and momentum of the newly-established National Dermatologist Day.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.